Physician profile
Timothy E Marra
NPI 1154391332
$1,994.74
in general payments reported to CMS, 2019-2025
14 companies · $255 in 2025
The $255 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $449 · 2020: $141 · 2021: $44.86 · 2022: $124 · 2023: $422 · 2024: $559 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,235.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $333.95 | 2020-2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Alcon Vision LLC | $273.73 | 2019-2025 | Tryptyr, Clareon, Simbrinza |
| Novartis Pharmaceuticals Corporation | $266.58 | 2019-2021 | |
| Rxsight INC | $236.20 | 2023-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Bausch & Lomb Americas INC. | $144.23 | 2023-2024 | Miebo, Xiidra, Vyzulta |
| Aerie Pharmaceuticals, INC. | $137.99 | 2019 | |
| Ocular Therapeutix, INC. | $137.02 | 2021-2024 | Dextenza |
| Tarsus Pharmaceuticals, INC. | $134.31 | 2024-2025 | Xdemvy |
| Abbvie INC. | $130.27 | 2023-2024 | |
| Johnson & Johnson Surgical Vision, INC. | $109.66 | 2023-2024 | Tecnis Simplicity, Tecnis Iol |
| Apellis Pharmaceuticals, INC. | $30.98 | 2025 | Syfovre |
| Amgen INC. | $21.84 | 2025 | Tepezza |
| Omeros Corporation | $21.09 | 2019 | |
| Oyster Point Pharma, INC. | $16.89 | 2023 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Marra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.